Clinical trials
Completed Phase 2 Leukemia, Mast-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jason Robert Gotlib | 2 |
| Novartis Pharmaceuticals | 2 |
| Asan Medical Center | 1 |
| Blueprint Medicines Corporation | 1 |
| Fred Hutchinson Cancer Center | 1 |
| M.D. Anderson Cancer Center | 1 |
| Mayo Clinic | 1 |
| Stanford University | 1 |
| Wake Forest University Health Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Mast-Cell | 11 |
| Mastocytosis, Systemic | 5 |
| Leukemia | 4 |
| Leukemia, Biphenotypic, Acute | 4 |
| Lymphoma, Mantle-Cell | 4 |
| Multiple Myeloma | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Burkitt Lymphoma | 3 |
| Hodgkin Disease | 3 |
| Immunoblastic Lymphadenopathy | 3 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.